TipRanks
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market
RNAC
Cartesian Therapeutics
RESEARCH TOOLSreports
Want to see RNAC full AI Analyst Report?

Cartesian Therapeutics (RNAC) Stock News & Sentiment

1,212 Followers
Cartesian Therapeutics Reports Encouraging Descartes-08 Retreatment Data
Premium
Company Announcements
Cartesian Therapeutics Reports Encouraging Descartes-08 Retreatment Data
9d ago
8K
RNAC
Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating
Premium
Ratings
Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating
2M ago
RNAC
Buy Rating Reiterated on Strong Cash Runway and Near‑Term Clinical Catalysts; $40 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Strong Cash Runway and Near‑Term Clinical Catalysts; $40 Price Target Maintained
2M ago
RNAC
Cartesian Therapeutics Shareholders Back Directors and Governance Measures
Premium
Company Announcements
Cartesian Therapeutics Shareholders Back Directors and Governance Measures
4M ago
8K
RNAC
Reiterating Buy on Cartesian: WestGene LNP Deal Expands In Vivo Pipeline and Catalyzes Long-Term Growth
Premium
Ratings
Reiterating Buy on Cartesian: WestGene LNP Deal Expands In Vivo Pipeline and Catalyzes Long-Term Growth
4M ago
RNAC
Cartesian Therapeutics Announces In Vivo CAR-T Licensing Alliance
Premium
Company Announcements
Cartesian Therapeutics Announces In Vivo CAR-T Licensing Alliance
4M ago
8K
RNAC
Cartesian Secures Major Loan Facility to Extend Runway
Premium
Company Announcements
Cartesian Secures Major Loan Facility to Extend Runway
4M ago
8K
RNAC
More RNAC News >

RNAC News on the Web

Cartesian Therapeutics Reports Encouraging Descartes-08 Retreatment Data
TipRanks News
Neutral
Cartesian Therapeutics (RNAC) Gets a Buy from Mizuho Securities
TipRanks News
Bullish
Cartesian Therapeutics: Late-Stage Descartes-08 De-Risking and 2027 Data Wave Underpin Van Buren’s Buy Rating
TipRanks News
Bullish
Cartesian Therapeutics (RNAC) Receives a Rating Update from a Top Analyst
TipRanks News
Bullish
Cartesian Therapeutics Shareholders Back Directors and Governance Measures
TipRanks News
Neutral
Cartesian Therapeutics Inc Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Cartesian Therapeutics (RNAC) and Cullinan Management (CGEM)
TipRanks News
Bullish
Wedbush Sticks to Their Buy Rating for Cartesian Therapeutics (RNAC)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average1.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RNAC’s Media Buzz Sentiment?
Currently, no data Available
What is RNAC’s weekly average amount of articles?
In an average week, 1.5 articles about RNAC are published.
    What is RNAC’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    XENEXenon
    ABTAbbott Laboratories
    BBIOBridgeBio Pharma
    BDXBecton Dickinson
    NVSNovartis
    Showing the stocks with the most bullish news sentiment over the past week